Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Background Observational studies showed that the profile of infective endocarditis (IE) significantly changed over the past decades. However, most studies involved referral centers. We conducted a population-based study to control for this referral bias. The objective was to update the description of characteristics of IE in France and to compare the profile of community-acquired versus healthcare-associated IE. Methods A prospective population-based observational study conducted in all medical facilities from 7 French regions (32% of French individuals aged ≥18 years) identified 497 adults with Duke-Li-definite IE who were first admitted to the hospital in 2008. Main measures included age-standardized and sex-standardized incidence of IE and multivariate Cox regression analysis for risk factors of in-hospital death. Results The age-standardized and sex-standardized annual incidence of IE was 33.8 (95% confidence interval [CI], 30.8-36.9) cases per million inhabitants. The incidence was highest in men aged 75-79 years. A majority of patients had no previously known heart disease. Staphylococci were the most common causal agents, accounting for 36.2% of cases (Staphylococcus aureus, 26.6%; coagulase-negative staphylococci, 9.7%). Healthcare-associated IE represented 26.7% of all cases and exhibited a clinical pattern significantly different from that of community-acquired IE. S. aureus as the causal agent of IE was the most important factor associated with in-hospital death in…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other studies [6][7][8] suggest that the risk of neurological deterioration during cardiac surgery after a stroke is lower than previously assumed, particularly in patients with silent cerebrovascular emboli.”
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742 · cited 1×
“residence, dates of first symptoms and first hospitalization, transfer from/to another facility, history of heart disease, comorbidities (including diabetes mellitus, cancer, dialysis, and immunosuppressive therapy), Charlson comorbidity index [13], procedures and other risk factors for IE, signs and symptoms of IE, e…”
BackgroundBurden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881 · cited 1×
“First, the decrease in rheumatic heart disease and the increase in degenerative heart diseases have led to an increase in patients’ age and frequency of comorbidities [2, 3].”
BackgroundProposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027 · cited 1×
“This process also included the validation of the diagnosis according to the Duke criteria modified by Li [20].”
MethodIung, B. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00201-x · Cited by 3,530 · cited 2×
“First, the decrease in rheumatic heart disease and the increase in degenerative heart diseases have led to an increase in patients’ age and frequency of comorbidities [2, 3].”
BackgroundSelf-citationMurdoch, D. R. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.603 · Cited by 2,362 · cited 3×
“pathogens in cases of IE [9]; these findings were later confirmed by different observational studies [1, 6].”
BackgroundResultSelf-citationFriedman, N. D., Kaye, K. S., Stout, J. E., McGarry, S. A., Trivette, S. L., Briggs, J. P., Lamm, W., Clark, C., MacFarquhar, J., Walton, A. L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00007 · Cited by 1,668 · cited 1×
“The mode of IE acquisition was categorized on the basis of 3 mutually exclusive classes: (1) injection drug use–associated IE, (2) community-acquired IE, and (3) healthcare-associated IE, which included nosocomial and nonnosocomial IE, according to prior definitions [6, 14–16] described in detail in the supplementary…”
MethodStaphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174 · cited 6×
“aureus IE study by Fowler et al [6].”
BackgroundMethodResultInfluentialSelf-citationJarraud, S., Mougel, C., Thioulouse, J., Lina, G., Meugnier, H., Forey, F., Nesme, X., Etienne, J., & Vandenesch, F. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.631-641.2002 · Cited by 1,151 · cited 1×
“Microbiologists were asked to send all strains of streptococci and staphylococci to the corresponding national reference centers, where identification was confirmed on the basis of phenotypic and molecular microbiology techniques [17–19].”
BackgroundSelf-citationChanging Profile of Infective Endocarditis<SUBTITLE>Results of a 1-Year Survey in France</SUBTITLE>
Hoen, B. (2002) · JAMA · doi:10.1001/jama.288.1.75 · Cited by 987
Self-citationMoreillon, P., & Que, Y.-A. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15266-x · Cited by 861
Research works printed but not linked: 1
- 2002, Changing profile of infective endocarditis: results of a one-year survey in France in 1999, JAMA, 288, 75
Cited by
Items 401–500 of 790
Minimally invasive procedures for right side infective endocarditis: A targeted literature review
Wang, W., Itagaki, S., & Egorova, N. (2024) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.30967 · Cited by 5
Radionuclide Imaging of Infective Endocarditis
Ferro, P., Boni, R., Bartoli, F., Lazzeri, F., Slart, R. H. J. A., & Erba, P. A. (2023) · Cardiology Clinics · doi:10.1016/j.ccl.2023.01.011 · Cited by 5
Left atrial mural endocarditis in the absence of significant structural heart disease
Malas, W., Ikram, M., Ruge, M., Mehta, P. K., & Chen, S. (2021) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2021.100009 · Cited by 5
“The highest incidence of IE occurs in those 70 to 75 years old, and mul- tipleriskfactorshavebeenassociatedwiththeconditionincludingthepres-ence of a prosthetic valve, intracardiac device, hemodialysis, diabetes mellitus, and intravenous drug use [6].”
BackgroundEndocarditis infecciosa: del diagnóstico al tratamiento
Fernandez‐Gerlinger, M., & Mainardi, J. (2016) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(16)80656-x · Cited by 5
Polymicrobial endocarditis: Chronic Q fever and Enterococcus faecalis coinfection
Mora-Rillo, M., Martín-Suñé, N., Romero‐Gómez, M. P., & Fernández-Capitán, M. C. (2013) · Revista Clínica Española · doi:10.1016/j.rce.2012.11.009 · Cited by 5
Multidrug-Resistant Gram-Positive Bacterial Infections
Jung, Y., & Kim, H. B. (2015) · Korean Journal of Medicine · doi:10.3904/kjm.2015.88.5.487 · Cited by 5
“황색포도알균에 의한 심내막염은 지난 20년 동안 증가하는 추세로 최근에는 심내막염을 일으키는 원인균 중 25-35%를 차지한다[31,32].”
Destrem, A.-L., Maillard, A., Simonet, M., Siméon, S., Contejean, A., Vignau, C., Pires, L., Isnard, M., Vitrat, V., Delory, T., et al. (2024) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-024-04851-6 · Cited by 5
“Staphylococcus aureus has become the most common pathogen, and the main cause of poor outcomes [3], while coagulase-negative staphylococci have emerged as major pathogens in prosthetic valve-asso - ciated endocarditis [4].”
Capilla, E., Poyet, R., Tortat, A. V., Marchi, J., Brocq, F.-X., Pons, F., Kerebel, S., Jégo, C., Mayet, A., & Cellarier, G. R. (2017) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2016.09.042 · Cited by 5
Bonifácio, B. V. (2014) · Americanae (AECID Library) · Cited by 5
Vural, Ö., Yılmaz, Ö., Gedikli, Ö., & Taş, A. (2025) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2025.2511519 · Cited by 5
“Studies conducted in developed countries have reported the mean age of IE patients as >60 years [5,7].”
Optimal Timing for Cardiac Surgery in Infective Endocarditis: Is Earlier Better?
Delahaye, F., Antchouey, A.-M., & de Gévigney, G. (2014) · Current Infectious Disease Reports · doi:10.1007/s11908-014-0411-3 · Cited by 5
Self-citationBellouard, R., Rambaud, A., Delaunay, C., Dailly, É., Lecomte, R., Deschanvres, C., Leroy, A., Boutoille, D., Turnier, P. L., Grégoire, M., et al. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad030 · Cited by 5
Yamashita, S., Tago, M., Motomura, S., Oie, S., Aihara, H., Katsuki, N. E., & Yamashita, S. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s324166 · Cited by 5
Staphylococcus lugdunensisEndocarditis in a 35-Year-Old Woman in Her 24th Week of Pregnancy
Khafaga, M., Kresoja, K., Urlesberger, B., Knez, I., Klaritsch, P., Lumenta, D. B., Krause, R. G. E., & von Lewinski, D. (2016) · Case Reports in Obstetrics and Gynecology · doi:10.1155/2016/7030382 · Cited by 5
“At present, Staphylococcus aureus is both the leading cause and the most important prognostic factor for infective endocarditis [10].”
BackgroundMitro-aortic infective endocarditis on bicuspid aortic valve multicomplicated: a case report
Boutaybi, M., Doudouh, O., Darar, C., Abbassi, O. E., Ismaili, N., & Ouafi, N. E. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000000745 · Cited by 5
“The enterococcus isolated from our patient was not the most frequently isolated bacterium in simple or complicated endocarditis; it ranked third after staphylococcus and streptococcus([6]).”
BackgroundSuzuki, T., Mawatari, M., Iizuka, T., Amano, T., Kutsuna, S., Fujiya, Y., Takeshita, N., Hayakawa, K., & Ohmagari, N. (2017) · Internal Medicine · doi:10.2169/internalmedicine.8411-16 · Cited by 5
Wang, F., Zhou, Z., Teng, J., Sun, Y., You, Y., Su, Y., Hu, Q., Liu, H., Cheng, X., Shi, H., et al. (2022) · Clinical Rheumatology · doi:10.1007/s10067-022-06313-w · Cited by 5
Diallo, K., Jacquet, C., Alauzet, C., Béguinot, I., May, T., Selton‐Suty, C., Hoen, B., & Goehringer, F. (2019) · Medicine · doi:10.1097/md.0000000000015014 · Cited by 5
“In 1 study, the median duration of symptoms before diagnosis of C hominis IE was 138 days ± 128.([7]) C hominis is a gram-negative bacillus that belongs to the HACEK group, a group of fastidiously-growing bacteria from of the oropharyngeal microbiota.”
BackgroundSelf-citationBeaufrère, M., Pressat-Laffouilhère, T., Marcelli, C., Michon, J., Lequerré, T., Prum-Delepine, C., Fiaux, E., Rasoldier, V., Etienne, M., Savouré, A., et al. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2021.08.008 · Cited by 5
Characteristics of patients with infective endocarditis and no underlying cardiac conditions
Mandjee, A. R., Filippetti, L., Goehringer, F., Duval, X., Botelho-Nevers, É., Tribouilloy, C. M., Huguet, R., Chirouze, C., Erpelding, M., Hoen, B., et al. (2022) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2022.2078404 · Cited by 5
“In recent studies, the incidence of IE was higher in patients with than without UCC [1,3].”
BackgroundSelf-citationInfective endocarditis in Portugal: Changing epidemiology but still a deadly disease
Habib, G. (2021) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2021.01.006 · Cited by 5
Lecomte, R., Deschanvres, C., Bourreau, A., d’Epenoux, L. R., Turnier, P. L., Gaborit, B. J., Chauveau, M., Michel, M., Tourneau, T. L., Bémer, P., et al. (2024) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2024.106989 · Cited by 4
Anton, C.-I., Ștefan, I., Dumitrache, S. M., Ștefan, A.-T., Răduț, D., Nistor, C., Ranetti, A.-E., Sîrbu, C. A., & Radu, F. I. (2024) · Microorganisms · doi:10.3390/microorganisms12050910 · Cited by 4
Fernando, R. J., Johnson, S. D., Augoustides, J. G., Patel, P. A., Gutsche, J. T., Dashiell, J. M., Feinman, J. W., Zhou, E., Weiss, S. J., Goldhammer, J. E., et al. (2017) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2017.07.031 · Cited by 4
Infective Endocarditis After Transcatheter Aortic Valve Replacement: A Narrative Review
Nappi, F. (2024) · Prosthesis · doi:10.3390/prosthesis6060110 · Cited by 4
“It is now acquired in over 25% of cases [20,21].”
Ai, S., Liu, X., Zhao, N., Miao, Q., Qin, Y., & Li, X. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2482023 · Cited by 4
Traitement de l’endocardite infectieuse
Hoen, B., Elfarra, M., Huttin, O., Goehringer, F., Venner, C., & Selton‐Suty, C. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.04.015 · Cited by 4
Self-citationRelevance of cardiac imaging in the evolving landscape of infective endocarditis management
Haouzi, A. A., Khayata, M., & Xu, B. (2024) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/17539447241305587 · Cited by 4
Les endocardites fongiques : mise au point
Fillâtre, P., Revest, M., & Tattevin, P. (2016) · Réanimation · doi:10.1007/s13546-016-1199-y · Cited by 4
Self-citationCloître, A., Hascoët, E., Iung, B., Duval, X., & Lesclous, P. (2021) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.24885 · Cited by 4
“It is well documented that cutaneous portal of entry (POE) is predominant for IE, but an oral POE is identified as the second most frequent source in about 30% of the IE patients (4,5).”
BackgroundSelf-citationJaime-Ardila, L. J., Támara-Rivera, J. L., Nócua-Báez, L. C., Díaz‐Brochero, C., & Meléndez-Rhenals, S. (2025) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361251384146 · Cited by 4
“4,30 In our analysis, hospital stay and bacteremia duration were similar across treatment groups, suggesting that cefazolin as a first-line option does not negatively affect these outcomes.”
Endocarditis infecciosa: del diagnóstico al tratamiento
Paz, D. L., Lakbar, I., & Tattevin, P. (2022) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(22)46449-x · Cited by 4
Management of MRSA/GISA, VISA Endocarditis
Jacqueline, C., Caillon, J., & Boutoille, D. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0349-x · Cited by 4
“The implementation of these materials has grown exponentially over the past decade, along with an even larger increase in the incidence of infections [12].”
BackgroundBłach, A., & Kwieciński, J. (2023) · Diagnostics · doi:10.3390/diagnostics13101791 · Cited by 4
“valves and coagulase-negative staphylococci on artificial implants, followed by viridans streptococci [52,53].”
Lefèvre, B., Legoff, A., Boutrou, M., Goehringer, F., Sime, W. N., Chirouze, C., Revest, M., Garnier, V. V., Duval, X., Delahaye, F., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1053278 · Cited by 4
Self-citationSogomonian, R., Alkhawam, H., Vyas, N., Jolly, J., Nguyen, J., Haftevani, E. A. M., Al‐Khazraji, A., & Ashraf, A. (2016) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.3402/jchimp.v6.30860 · Cited by 4
“aureus with the highest in-hospital mortality rates (6, 7).”
BackgroundStaphylococcus lugdunensis infective endocarditis: a multicentre international observational study
Lefèvre, B., Habib, G., Hoen, B., Selton‐Suty, C., Philip, M., Issa, N., Danneels, P., de la Chapelle, M., Deschanvres, C., Erpelding, M., et al. (2025) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2025.2556921 · Cited by 4
“%) of healthcare-related cases in SLIE [11,16,18,19], which was also present in 44.5% in the Spanish series of SLIE [17].”
InfluentialSelf-citationNappi, F., & Singh, S. S. A. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13400-9 · Cited by 4
Chirouze, C., Hoen, B., & Duval, X. (2014) · Current Infectious Disease Reports · doi:10.1007/s11908-014-0440-y · Cited by 4
Self-citationNative Triple Valve Endocarditis as Complication of Post-Abortal Sepsis
Maturu, M. V. S., Devasia, T., Rao, M. S., & Kareem, H. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/20551.8147 · Cited by 4
Early results for active infective endocarditis
Aithoussa, M., Atmani, N., Mounir, R., Moutakiallah, Y., Bamous, M., Abdou, A., Nya, F., Seghrouchni, A., Bellouize, S., Drissi, M., et al. (2017) · Pan African Medical Journal · doi:10.11604/pamj.2017.28.245.13518 · Cited by 4
Severe Thrombocytopenia in Infective Endocarditis
PATEL, M. J., Adhikari, B., Devkota, A., & Mohebtash, M. (2023) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.55729/2000-9666.1272 · Cited by 4
Diffusion of amoxicillin into heart valves from infective endocarditis patients
Lalanne, S., Guérin, F., Flecher, E. M., Cattoir, V., Nesseler, N., Revest, M., & Verdier, M. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac379 · Cited by 4
Self-citationProphylaxis of Infective Endocarditis
Durack, D. T. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00085-0 · Cited by 4
Taranova, M. V., Androsova, T. V., Kozlovskaya, L. V., Strizhakov, L. A., Lebedeva, M. V., Milovanova, L. Y., & Mukhin, N. A. (2018) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2018-96-2-129-136 · Cited by 4
Systemic Factors Affecting Orthodontic Treatment Outcomes and Prognosis–Part 2
Ardeshna, A. P., Gupta, S. K., Rossouw, P. E., & Valiathan, M. (2024) · Dental Clinics of North America · doi:10.1016/j.cden.2024.05.005 · Cited by 4
Honarbakhsh, S., Chowdhury, M. M., Farooqi, F., & Deaner, A. (2015) · BMJ Case Reports · doi:10.1136/bcr-2015-211920 · Cited by 4
“IE secondary to S. aureus is well recognised to be associated with increased mortality 10 and has been reported as the most important prognostic factor, 11 as it is known to cause aggressive and rapid progression of IE.”
Ai, S., Feng, X., Sun, K., Chen, G., Liu, X., Miao, Q., Qin, Y., & Li, X. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae382 · Cited by 4
Vallejo, N., Cediel, G., Aragón, R. N., Mateu, L., Llibre, C., Sopena, N., Gual‐Capllonch, F., Ferrer, E., Quesada, M. D., Berastegui, E., et al. (2020) · Revista Española de Cardiología · doi:10.1016/j.recesp.2019.09.023 · Cited by 4
“EuroSCORE I (%) 20 [9-39] 14 [7-28] 34 [16-54] < 0,001 25 [12-41] 28 [15-47] 0,304”
Kolluru, A., Behera, S., Damarla, V. K., & Rajasurya, V. (2020) · Cureus · doi:10.7759/cureus.10249 · Cited by 4
“Healthcare-associated IE is an emerging facet of the disease, which is a source of concern because of its frequency and severity [3].”
BackgroundKoike, M., Doi, T., Morishita, K., Uruno, K., Nabuchi, M., Komuro, K., Iwano, H., Naraoka, S., Nagahara, D., & Yuda, S. (2024) · International Heart Journal · doi:10.1536/ihj.23-360 · Cited by 4
Síndrome del dedo azul: de la piel a lo multisistémico
Cross, A. E., Guerra, P. A., Restrepo, M. P., & Restrepo, A. C. (2022) · Revista Argentina de Reumatología · doi:10.47196/rar.v33i3.676 · Cited by 4
Infective Endocarditis Due to Haemophilus parainfluenzae: A Case Report and Review of the Literature
Rabinovich, D., Yazigi, M., Yazigi, A., & Zainah, H. (2023) · Journal of Brown Hospital Medicine · doi:10.56305/001c.77739 · Cited by 4
Kyhl, F., Rasmussen, R. V., Lindhardsen, J., Smerup, M., & Fosbøl, E. L. (2021) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytaa561 · Cited by 4
Rajesh, G. N., Vellani, H., Jose, J. V., Mohanan, S., & Sajeev, C. G. (2022) · Indian Heart Journal · doi:10.1016/j.ihj.2022.05.003 · Cited by 4
Kaki, R., & Al‐Abdullah, N. (2018) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2018.63.68 · Cited by 4
Ak, H. Y., Özşahin, Y., Yeşiltaş, M. A., Haberal, İ., Kahraman, S., Okşen, D., & Yıldız, M. (2021) · The Heart Surgery Forum · doi:10.1532/hsf.3715 · Cited by 4
No Fever, No Murmur, No Problem? A Concealed Case of Infective Endocarditis
McCann, M., Gorman, M., & McKeown, B. (2019) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2019.03.002 · Cited by 4
Zeouk, I. (2023) · Notulae Scientia Biologicae · doi:10.55779/nsb15111402 · Cited by 3
Hematologic Parameters as Predictors of Long-Term Mortality in Infective Endocarditis Patients
Gülaştı, S., Zencır, C., Çayırlı, S., Mutlu, B., & Öztürk, Ş. B. (2023) · Medical Science Monitor · doi:10.12659/msm.941758 · Cited by 3
Perdigão, L. A. M., Soares, F. H. C., Melo, L. M. F., & Paula, M. M. D. M. (2022) · Editora Pasteur eBooks · doi:10.29327/562623.1-9 · Cited by 3
Fichadiya, H. A., Shah, K. K., Noori, M. A. M., Khandait, H. V., Rath, P., Latif, A., Patel, R. K., & Pullatt, R. C. (2022) · Cureus · doi:10.7759/cureus.25314 · Cited by 3
“The most common risk factor for eustachian valve endocarditis is intravenous drug use, whereas central venous catheters, pacemakers, congenital heart disease, history of rheumatic heart disease, chronic alcoholism, and HIV are also associated with increased risk [5].”
BackgroundDefinition and Epidemiology of Infective Endocarditis
Tleyjeh, I. M., & Abdulhak, A. A. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-32432-6_1 · Cited by 3
Heydari, A. A., Eslami, A., & Dadgarmoghaddam, M. (2021) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.116313 · Cited by 3
Desaint, P., Chauvat, A., Garaud, T., Andremont, O., Plantefève, G., Mentec, H., & Contou, D. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.10.013 · Cited by 3
Diagnostic de l’endocardite infectieuse
Delahaye, F., & de Gévigney, G. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.04.016 · Cited by 3
Self-citationInfective endocarditis: Surgical management and prognostic predictors
Moreira, R. I., Cruz, M. C., Branco, L. M., Galrinho, A., Miranda, L. C., Fragata, J., & Ferreira, R. C. (2018) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2017.08.007 · Cited by 3
Infectious Complications in Infective Endocarditis
Hayley, B. D., & Chan, K. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-32432-6_10 · Cited by 3
Kloss, M., Moerke, C., Woitschach, F., Wulf, K., Illner, S., Schulz, S., Pauker, V. I., Riedel, K., Grabow, N., İnce, H., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1021827 · Cited by 3
Infective Endocarditis: A Review of the Past and Present, and a Look into the Future
Jeng, E. I.-H., Hall, D. J., Matthews, C. R., Manning, E. W., & Beaver, T. M. (2017) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2017.0010 · Cited by 3
Yee, R., Yuan, Y., Tarff, A., Brayton, C. F., Gour, N., Feng, J., Shi, W., & Zhang, Y. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/686097 · Cited by 3
Simplification of the prophylaxis of endocarditis: We were right!
Duval, X. (2013) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2013.02.001 · Cited by 3
Self-citationDéveloppement professionnel continu (DPC) : l’antibioprophylaxie
Slama, L. B. (2013) · Revue de Stomatologie de Chirurgie Maxillo-faciale et de Chirurgie Orale · doi:10.1016/j.revsto.2013.04.002 · Cited by 3
Yamashita, S., Tago, M., Tokushima, M., Nakashima, T., Katsuki, N. E., Anzai, K., & Yamashita, S. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s264497 · Cited by 3
Extended spectrum beta lactamase producing Escherichia coli tricuspid valve endocarditis
Waked, R., Saliba, G., Chehata, N., Haddad, É., Chedid, M., & Choucair, J. (2020) · IDCases · doi:10.1016/j.idcr.2020.e00729 · Cited by 3
“Infective endocarditis is a rare disease accounting for 3–10 new cases per 100,000 people per year [1,2].”
BackgroundAzelmat, S., Baadi, T., Benaissa, E., Jaafari, A., & Chadli, M. (2024) · Cureus · doi:10.7759/cureus.64639 · Cited by 3
Selton‐Suty, C., Lalloué, B., Goehringer, F., Alla, F., Botelho-Nevers, É., Curlier, E., Eicher, J., Hatimi, S. E., Escaut, L., Gagneux‐Brunon, A., et al. (2025) · Heart · doi:10.1136/heartjnl-2025-326357 · Cited by 3
Self-citationMultidrug-Resistant Salmonella Endocarditis of a Native Valve: A Rare Case Presentation
Zahoor, M., Ahmad, K., Kakakhel, M., Yousaf, A., Saleh, M., Sayyar, M., & Ali, Y. (2023) · Cureus · doi:10.7759/cureus.48396 · Cited by 3
“These organisms are responsible for 80-90% of all endocarditis cases [4].”
BackgroundInfectious Endocarditis in the Elderly – Comparative Study of Clinical Features, Course and Outcomes
Чипигина, Н. С., Karpova, N. Y., Anichkov, D. A., & Борисовна, К. Т. (2020) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2020-03-02 · Cited by 3
Асанов, М. А., Kazachek, Y. V., Evtushenko, A. V., Teplova, Y. E., & Ponasenko, A. V. (2022) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2022-7.2.10 · Cited by 3
Jatteppanavar, B., Choudhury, A., Panda, P. K., & Bairwa, M. C. (2024) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v13.i1.87459 · Cited by 3
Yingchoncharoen, T. (2015) · Springer eBooks · doi:10.1007/978-1-4471-6672-6_7 · Cited by 3
Fareed, F. F. I., Kumar, N. S., Singh, R., & Awad, W. I. (2025) · Journal of Surgical Protocols and Research Methodologies · doi:10.1093/jsprm/snaf004 · Cited by 2
Kitano, T., & Yoshida, S. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf246 · Cited by 2
Na, K. W., Kim, J. S., & Kim, H. J. (2016) · Pediatric Infection & Vaccine · doi:10.14776/piv.2016.23.3.229 · Cited by 2
Endocarditis in critically ill patients: a review
Nedel, W. L., Boniatti, M. M., & Lisboa, T. C. (2023) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001071 · Cited by 2
Whitehead, T., Moore, A. B., Agarwal, A., & Appleby, J. (2023) · BMJ Case Reports · doi:10.1136/bcr-2022-250098 · Cited by 2
Is Glasgow prognostic score a predictor of mortality in infective endocarditis?
Emlek, N., Özyıldız, A. G., Şahin, M. A., Ergül, E., & Aydın, C. (2022) · The European Research Journal · doi:10.18621/eurj.1100926 · Cited by 2
Antibiothérapie des endocardites infectieuses en 2021 : actualités
Paz, D. L., Bot, A. L., Sebillotte, M., Tchamgoué, S., Lebeaux, D., & Tattevin, P. (2021) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/j.amcp.2021.03.002 · Cited by 2
Lin, Y.-C., Zheng, J.-F., & Lin, Y.-H. (2018) · 內科學誌 · doi:10.6314/jimt.201810_29(5).05 · Cited by 2
Neutrophil Gelatinase-associated Lipocalin: A Potential Predictor of Embolic Events in Endocarditis
Huang, S., Yuan, Y., Liang, M., Feng, K., Hou, J., Li, H., Huang, X., Huang, L., Chen, G., & Wu, Z. (2021) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2021.04.060 · Cited by 2
Infective Endocarditis and Cardiovascular Implantable Electronic Device Infection
Sollini, M., Bandera, F., Bartoli, F., Zanca, R., Lazzeri, E., & Erba, P. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-62175-9_9 · Cited by 2
Hindy, J.-R., Chesdachai, S., DeSimone, D. C., Anavekar, N. S., Stevens, R. W., Arghami, A., & Baddour, L. M. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.09.012 · Cited by 2
Infective Endocarditis: A Contemporary Review of Epidemiology, Diagnosis, and Management
Ishak, A., Qadeer, Y. K., AlRawashdeh, M. M., Yue, B., Khawaja, M., Strauß, M., & Krittanawong, C. (2026) · Antibiotics · doi:10.3390/antibiotics15050482 · Cited by 2
Siciliano, R. F. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-13082014-161310 · Cited by 2
Shah, T., Hamill, R. J., & Ramasubbu, K. (2019) · Cardiovascular medicine · doi:10.1007/978-1-4471-2840-3_3 · Cited by 2
Barot, H., & Alsindi, F. (2017) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2016.11.005 · Cited by 2
Tratamiento quirúrgico de la endocarditis mediante cirugía mínimamente invasiva
Velásquez, Ó., Matar, O. A., & Jaimes, F. A. (2018) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2018.03.010 · Cited by 2
Chesdachai, S., DeSimone, D. C., & Baddour, L. M. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.10.110 · Cited by 2
Infective endocarditis in 2018
Pelouch, R. (2018) · Intervenční a akutní kardiologie · doi:10.36290/kar.2018.041 · Cited by 2
Metadata
- Authors
- Selton-Suty, C., Célard, M., Le Moing, V., Doco-Lecompte, T., Chirouze, C., Iung, B., Strady, C., Revest, M., Vandenesch, F., Bouvet, A., Delahaye, F., Alla, F., Duval, X., & Hoen, B.
- Affiliations
- Laboratoire Chrono-Environnement (FR)
- Hôpital Pontchaillou (FR)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Hôpital Bichat-Claude-Bernard (FR)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-05-01
- Volume
- 54
- Issue
- 9
- Pages
- 1230-1239
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2155794989
- Semantic Scholar
- 46e2ed77823a43f31fbb6342dfb12aabb30be85d
- Cited by
- 710
- References
- 29
- Citations by year
- 2026: 30 · 2025: 37 · 2024: 55 · 2023: 66 · 2022: 64 · 2021: 51 · 2020: 65 · 2019: 67 · 2018: 42 · 2017: 53 · 2016: 56 · 2015: 47 · 2014: 32 · 2013: 35 · 2012: 8
- FWCI
- 29.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- infective endocarditis, Staphylococcus aureus, coagulase-negative staphylococci, community-acquired endocarditis, incidence, in-hospital mortality, risk factors, referral bias
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Cross Infection, Endocarditis, Bacterial, Female, France, Hospitals, Humans, Male, Middle Aged, Population Surveillance, Prognosis, Risk Factors, Staphylococcal Infections, Staphylococcus, Staphylococcus aureus, Incidence, Community-Acquired Infections, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.